AtriCure Newsroom

A Quick Look at Today's Ratings for AtriCure(ATRC.US), With a Forecast Between $36 to $60

Futu NewsOct 31 21:21

AtriCure Is Maintained at Overweight by JP Morgan

Dow JonesOct 30 23:30

UBS Maintains Buy on AtriCure, Raises Price Target to $40

BenzingaOct 30 21:35

A Quick Look at Today's Ratings for AtriCure(ATRC.US), With a Forecast Between $36 to $60

Futu NewsOct 30 21:13

AtriCure Analyst Ratings

BenzingaOct 30 18:57

CCORF Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $49

Futu NewsAug 14 19:35

Atricure's Market Strength and Innovation Justify Buy Rating

TipRanksAug 14 19:24

Oppenheimer Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $32

Futu NewsAug 1 12:31

Navigating 6 Analyst Ratings For AtriCure

BenzingaAug 1 03:02

AtriCure Price Target Cut to $53.00/Share From $58.00 by BTIG

Dow JonesAug 1 02:55

JP Morgan Maintains Overweight on AtriCure, Lowers Price Target to $30

BenzingaAug 1 02:33

A Quick Look at Today's Ratings for AtriCure(ATRC.US), With a Forecast Between $26 to $60

Futu NewsJul 31 21:02

Needham Maintains Buy on AtriCure, Lowers Price Target to $34

BenzingaJul 31 20:05

AtriCure Price Target Cut to $40.00/Share From $65.00 by Piper Sandler

Dow JonesJul 31 19:52

AtriCure Analyst Ratings

BenzingaJul 31 19:43

Analysts Are Bullish on These Healthcare Stocks: Incyte (INCY), Atricure (ATRC)

TipRanksJul 31 18:54

Piper Sandler Remains a Buy on Atricure (ATRC)

TipRanksJul 31 18:54

Atricure's Stable Financials and Strategic Growth Outlook Justify Buy Rating

TipRanksJul 31 18:40

AtriCure's Growth Prospects and Buy Rating Despite Short-Term Challenges

TipRanksJul 31 12:53

Analyst Ratings For AtriCure

BenzingaJul 9 03:02